Related Experiment Videos
Androgen dynamics in vitro in the normal and hyperplastic human prostate gland
The Biochemical Journal
|June 1, 1971
Summary
Androgen uptake and metabolism in prostate tissues show differences between normal and hyperplastic glands at higher concentrations. Hyperplastic glands exhibit disproportionately high tissue uptake of androgens when steroid levels increase.
Area of Science:
- Endocrinology
- Urology
- Biochemistry
Background:
- Androgens play a crucial role in prostate function and disease.
- Understanding androgen dynamics in normal versus hyperplastic prostate tissue is vital for therapeutic strategies.
Purpose of the Study:
- To investigate the in vitro dynamics of androgen uptake and metabolism in normal and hyperplastic human prostate glands.
- To compare the steady-state kinetics of testosterone, androstenedione, and 5α-dihydrotestosterone in different prostate tissue types.
Main Methods:
- Utilized a novel experimental design involving perfusion of prostate slices with radiolabeled androgens.
- Measured androgen entry, irreversible metabolism, interconversion, and tissue retention at steady state.
- Compared parameters at physiological and elevated steroid concentrations (0.11 μmol/l and 1.1 μmol/l).
Main Results:
- All three studied androgens (testosterone, androstenedione, 5α-dihydrotestosterone) showed similar entry and irreversible metabolism rates.
- Conversion of testosterone to 5α-dihydrotestosterone was significantly higher than other interconversions.
- Prostate slices preferentially retained 5α-dihydrotestosterone compared to testosterone and androstenedione.
- At elevated steroid concentrations, hyperplastic glands showed lagged metabolism and disproportionately high tissue uptake compared to normal glands.
Conclusions:
- Prostate tissue exhibits specific retention of 5α-dihydrotestosterone.
- Differences in androgen uptake and metabolism dynamics emerge between normal and hyperplastic prostate tissues at higher androgen concentrations.
- These findings suggest altered androgen handling in benign prostatic hyperplasia that may have clinical implications.